Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05179_nanopub.RAyifEPCaUMiItCADtEbY2sU5cwupYsGfXZwUP_cItp0M#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05179 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05179 label "DLO6002 [drugbank:DB05179]" assertion.
- drugbank:DB05179 seeAlso DB05179 assertion.
- drugbank:DB05179 description "DLO6002 is developed by Summit Corporation and is in phase I of clinical trials for the treatment of Parkinson's disease." assertion.
- drugbank:DB05179 identifier "drugbank:DB05179" assertion.
- drugbank:DB05179 title "DLO6002" assertion.
- drugbank:DB05179 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05179 drugbank_vocabulary:drugbank-id "DB05179" assertion.
- drugbank:DB05179 bio2rdf_vocabulary:x-identifiers.org DB05179 assertion.
- drugbank:DB05179 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05179" assertion.
- drugbank:DB05179 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05179 bio2rdf_vocabulary:identifier "DB05179" assertion.